Background illustration for clinical trials search

Paid Clinical Trials Arizona

Discover 1,569 paid clinical trials in Arizona. Search by city or condition to find a research study near you that matches your needs across various therapeutic areas.

Filter
1

Study Evaluating the Efficacy of KITE-753 Versus Axicabtagene Ciloleucel in Participants With Relapsed or Refractory Large B-Cell Lymphoma After First-Line Therapy

for
Relapsed or Refractory Large B-cell Lymphoma
Location: New Haven CT, Quebec, New York NY, Montreal,
Sponsor: Kite, A Gilead Company

Sex: All

Age: 18+

Code: NCT07479797

Phase3, Recruiting

A Study of Zanzalintinib in Participants With Recurrent or Progressive Meningioma

for
Meningioma
Location: Boston MA, Providence RI, New York NY, Fairfax VA,
Sponsor: Exelixis

Sex: All

Age: 18+

Code: NCT07428616

Phase2, Recruiting

Study to Evaluate HM15275 in Subjects With Type 2 Diabetes Mellitus

for
Type 2 Diabetes Mellitus, T2DM
Location: Morehead City NC, Manassas VA, DeLand FL, Orlando FL,
Sponsor: Hanmi Pharmaceutical Company Limited

Sex: All

Age: 18 - 70+

Code: NCT07527650

Phase2, Recruiting

Pegtibatinase as a Treatment for Participants With Classical Homocystinuria (HCU) Receiving Standard of Care Treatment

for
Homocystinuria
Location: Portland ME, New Haven CT, New York NY, Philadelphia PA,
Sponsor: Travere Therapeutics, Inc.

Sex: All

Age: 12 - 65

Code: NCT06247085

Phase3, Recruiting

ALTO-207 in Adults With Treatment-resistant Depression (TRD)

for
Treatment-resistant Depression (TRD)
Location: Annapolis MD, Savannah GA, Saint Augustine FL,
Sponsor: Alto Neuroscience

Sex: All

Age: 18 - 70+

Code: NCT07553637

Phase2, Recruiting

Interested in new trials?

Get alerts for new trials in your area by subscribing now

Subscriber Image

LY4268989 in Adults With Moderately to Severely Active Ulcerative Colitis

for
Ulcerative Colitis (UC), Ulcerative Colitis, Active Moderate,
Location: New Brunswick NJ, Greenville NC, Wilmington NC,
Sponsor: Eli Lilly and Company

Sex: All

Age: 18 - 70+

Code: NCT07415044

Phase2, Recruiting

Dose Ranging Study of ORKA-002 in Patients With Moderate-to-Severe Plaque Psoriasis

for
Plaque Psoriasis
Location: Boston MA, Milford MA, Cromwell CT, Elmhurst NY,
Sponsor: Oruka Therapeutics, Inc.

Sex: All

Age: 18 - 70+

Code: NCT07474792

Phase2, Recruiting

Study of Reformulated Levulan Kerastick Plus PDT for Actinic Keratosis on Upper Extremities

for
Actinic Keratosis
Location: Plymouth Meeting PA, Aventura FL, North Miami Beach FL,
Sponsor: Sun Pharmaceutical Industries, Inc.

Sex: All

Age: 18 - 70+

Code: NCT07144852

Phase3, Recruiting

Study of Tarlatamab + ZL-1310 +/- Anti-programmed Death Ligand 1 (Anti-PD-L1) in Small Cell Lung Cancer (SCLC)

for
Small Cell Lung Cancer
Location: New York NY, Fairfax VA, Tampa FL, Zion IL, Memphis TN,
Sponsor: Amgen

Sex: All

Age: 18 - 70+

Code: NCT07531095

Phase1, Recruiting

Testing Whether High Dose Chemotherapy and Infusion of the Patients' Own Stem Cells Improves Survival in Patients With Peripheral T-cell Lymphoma Who Achieved a Complete Response at the End of the Initial Chemotherapy

for
Anaplastic Large Cell Lymphoma, ALK-Negative,
Location: Millville DE, Lewes DE, Rehoboth Beach DE,
Sponsor: Eastern Cooperative Oncology Group

Sex: All

Age: 18 - 70+

Code: NCT06724237

Phase3, Recruiting

Mobility Performance in Daily Activities Among Children Wearing Spectacle Lenses

for
Myopia, Myopia Progression, Juvenile Myopia
Location: Glendale AZ
Sponsor: SightGlass Vision, Inc.

Sex: All

Age: 6 - 12

Code: NCT07229352

Recruiting

Phase III Study of Datopotamab Deruxtecan Versus Docetaxel in Previously Treated TROP2-positive Advanced or Metastatic Non-squamous NSCLC Without Actionable Genomic Alterations

for
Non-small Cell Lung Cancer (NSCLC)
Location: Halifax, Moncton, South Portland ME, Boston MA,
Sponsor: AstraZeneca

Sex: All

Age: 18+

Code: NCT07291037

Phase3, Recruiting

Study of XmAb942 in Healthy Participants and Participants With Ulcerative Colitis

for
Ulcerative Colitis (UC)
Location: Albany NY, Richmond VA, Raleigh NC, Rochester NY,
Sponsor: Xencor, Inc.

Sex: All

Age: 18 - 70+

Code: NCT06619990

Phase1, Phase2, Recruiting

A Study of LY4005130 in Adult Participants With Non-Segmental Vitiligo

for
Vitiligo, Non-Segmental Vitiligo (NSV)
Location: Portsmouth NH, Boston MA, Chicoutimi, The Bronx NY,
Sponsor: Eli Lilly and Company

Sex: All

Age: 18 - 70+

Code: NCT07533019

Phase2, Recruiting

Testing the Addition of an Anti-cancer Drug, Selinexor, to the Usual Chemotherapy Treatment (Temozolomide) for Brain Tumors That Have Returned After Previous Treatment

for
Recurrent Glioblastoma, IDH-Wildtype,
Location: New York NY, New Brunswick NJ, Deerfield Beach FL,
Sponsor: National Cancer Institute (NCI)

Sex: All

Age: 18+

Code: NCT05432804

Phase1, Phase2, Recruiting

Study to Evaluate Tulisokibart in Adults With Psoriatic Arthritis (MK-7240-015)

for
Psoriatic Arthritis
Location: Rimouski, Brooklyn NY, Trois-Rivieres, Philadelphia PA,
Sponsor: Merck Sharp & Dohme LLC

Sex: All

Age: 18 - 70+

Code: NCT07486960

Phase2, Recruiting

Endotype DIrected Treatment for OSA in Down Syndrome

for
Obstructive Sleep Apnea (OSA), Down Syndrome
Location: Philadelphia PA, Miami FL, Park Ridge IL, Tucson AZ,
Sponsor: University of Arizona

Sex: All

Age: 6+

Code: NCT07280468

Recruiting

A Study to Assess the Safety and Efficacy of Different Doses of ELV001 to Treat Active Rheumatoid Arthritis in Patients With an Inadequate Response to Methotrexate and Tumor Necrosis Factor Inhibition (START SYNERGY)

for
Active Rheumatoid Arthritis
Location: Wyomissing PA, Wilmington NC, Boca Raton FL,
Sponsor: Elevara Medicines Limited

Sex: All

Age: 18 - 70+

Code: NCT07409103

Phase2, Recruiting

Dose Escalation Study Evaluating the Safety and Pharmacokinetics of VX-272 in Healthy Participants

for
Cystic Fibrosis
Location: Tempe AZ
Sponsor: Vertex Pharmaceuticals Incorporated

Sex: All

Age: 18 - 55

Code: NCT07437105

Phase1, Recruiting

A Study to Investigate Ubamatamab With and Without Marlotamig (REGN7075) in Adult Participants With Advanced/Metastatic Non-Small Cell Lung Cancer (NSCLC)

for
Non Small Cell Lung Cancer, Advanced Non Small Cell Lung Cancer,
Location: Newark DE, Baltimore MD, Washington D.C. DC,
Sponsor: Regeneron Pharmaceuticals

Sex: All

Age: 18+

Code: NCT07154290

Phase2, Recruiting

Popular cities in Arizona

With a diverse healthcare network and renowned medical research institutions, Arizona is a key player in clinical research. Leading clinical research organizations such as the Mayo Clinic in Phoenix, Banner Health, University of Arizona Health Sciences, and the Translational Genomics Research Institute (TGen) are driving medical research and innovation advancements. These institutions are at the forefront of clinical studies, contributing significantly to cutting-edge treatments and healthcare advancements across the state.

Why choose Arizona for clinical trials?

Participating in clinical trials in Arizona offers several unique advantages. First, due to the state being home to some of the nation's top research institutions, participants have access to cutting-edge treatments and advanced medical care. These institutions are leaders in fields like oncology, cardiology, and precision medicine, allowing participants to be at the forefront of groundbreaking medical advancements.

Another significant advantage is Arizona's diverse population, which allows for a broad range of clinical trials addressing different demographics and health conditions. This diversity increases the relevance of clinical trial outcomes across varied populations, ensuring more accurate and inclusive medical research. Additionally, Arizona’s pleasant climate and growing healthcare infrastructure make participation in trials more convenient and accessible, especially for those traveling to Phoenix or Tucson for care.

Common conditions studied in Arizona

Local regulations and guidelines

Benefits of participating in clinical trials

How to enroll in a clinical trial in Arizona